Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism RSK inhibitors(Ribosomal protein S6 kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H18N2O2 |
InChIKeyXASCINRGTHLHGM-UHFFFAOYSA-N |
CAS Registry376382-11-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | US | 09 Aug 2010 |